 |
12 Diseases |  |
1 Trial |
|
1 Trial |  |
83 News |  |
| «12 |
- basmisanil (RG1662) / Roche
Enrollment closed: A Study of the Effect of RG1662 on Metformin in Healthy Volunteers (clinicaltrials.gov) - May 12, 2015
P1, N=17, Active, not recruiting, Sponsor: Hoffmann-La Roche
Recruiting --> Active, not recruiting
- | basmisanil (RG1662) / Roche
Trial completion: A Study of RO5186582 Treatment on Cytochrome P450 (CYP) 3A4 Activity in Healthy Participants (clinicaltrials.gov) - Jan 28, 2015
P1, N=12, Completed, Sponsor: Hoffmann-La Roche
Recruiting --> Active, not recruiting Recruiting --> Completed
- ||| basmisanil (RG1662) / Roche
Trial completion, Enrollment change, Trial primary completion date: A Screening Protocol to Assess Adults and Adolescents With Down Syndrome for Eligibility For Upcoming Study of RG1662 (Study BP27832) (clinicaltrials.gov) - Jan 28, 2015
P=N/A, N=118, Completed, Sponsor: Hoffmann-La Roche
Recruiting --> Completed Recruiting --> Completed | N=170 --> 118 | Trial primary completion date: Dec 2015 --> Dec 2014
- | basmisanil (RG1662) / Roche
New P1 trial: A Study of the Effect of RG1662 on Metformin in Healthy Volunteers (clinicaltrials.gov) - Jan 22, 2015
P1, N=16, Recruiting, Sponsor: Hoffmann-La Roche
- || basmisanil (RG1662) / Roche
Trial primary completion date: A Screening Protocol to Assess Adults and Adolescents With Down Syndrome for Eligibility For Upcoming Study of RG1662 (Study BP27832) (clinicaltrials.gov) - Dec 25, 2014
P=N/A, N=170, Recruiting, Sponsor: Hoffmann-La Roche
Recruiting --> Completed | N=170 --> 118 | Trial primary completion date: Dec 2015 --> Dec 2014 Trial primary completion date: Sep 2015 --> Dec 2015
- || basmisanil (RG1662) / Roche
Trial primary completion date: A Study of RG1662 in Adults and Adolescents With Down Syndrome (CLEMATIS) (clinicaltrials.gov) - Nov 25, 2014
P2, N=180, Recruiting, Sponsor: Hoffmann-La Roche
Trial primary completion date: Sep 2015 --> Dec 2015 Trial primary completion date: Dec 2015 --> Aug 2015
- || basmisanil (RG1662) / Roche
Trial primary completion date: A Study of RG1662 in Adults and Adolescents With Down Syndrome (CLEMATIS) (clinicaltrials.gov) - Nov 4, 2014
P2, N=180, Recruiting, Sponsor: Hoffmann-La Roche
Trial primary completion date: Dec 2015 --> Aug 2015 Trial primary completion date: Aug 2015 --> Dec 2015
- | basmisanil (RG1662) / Roche
Trial completion: Comparative Bioavailability Study of Film-coated Tablet and Granule Formulations of RG1662 (clinicaltrials.gov) - Nov 4, 2014
P1, N=18, Completed, Sponsor: Hoffmann-La Roche
Trial primary completion date: Aug 2015 --> Dec 2015 Recruiting --> Completed
- || basmisanil (RG1662) / Roche
Trial primary completion date: A Study of RG1662 in Adults and Adolescents With Down Syndrome (CLEMATIS) (clinicaltrials.gov) - Oct 22, 2014
P2, N=180, Recruiting, Sponsor: Hoffmann-La Roche
Recruiting --> Completed Trial primary completion date: Nov 2015 --> Aug 2015
- || basmisanil (RG1662) / Roche
Trial primary completion date: A Study of RG1662 in Adults and Adolescents With Down Syndrome (CLEMATIS) (clinicaltrials.gov) - Oct 17, 2014
P2, N=180, Recruiting, Sponsor: Hoffmann-La Roche
Trial primary completion date: Nov 2015 --> Aug 2015 Trial primary completion date: Aug 2015 --> Nov 2015
- || basmisanil (RG1662) / Roche
Trial primary completion date: A Screening Protocol to Assess Adults and Adolescents With Down Syndrome for Eligibility For Upcoming Study of RG1662 (Study BP27832) (clinicaltrials.gov) - Oct 17, 2014
P=N/A, N=170, Recruiting, Sponsor: Hoffmann-La Roche
Trial primary completion date: Aug 2015 --> Nov 2015 Trial primary completion date: Aug 2014 --> Sep 2015
- | basmisanil (RG1662) / Roche
New P1 trial: A Study of RO5186582 Treatment on Cytochrome P450 (CYP) 3A4 Activity in Healthy Participants (clinicaltrials.gov) - Oct 2, 2014
P1, N=12, Recruiting, Sponsor: Hoffmann-La Roche
- | basmisanil (RG1662) / Roche
New P1 trial: Comparative Bioavailability Study of Film-coated Tablet and Granule Formulations of RG1662 (clinicaltrials.gov) - Jul 18, 2014
P1, N=18, Recruiting, Sponsor: Hoffmann-La Roche
- || basmisanil (RG1662) / Roche
Trial primary completion date: A Study of RG1662 in Adults and Adolescents With Down Syndrome (CLEMATIS) (clinicaltrials.gov) - May 13, 2014
P2, N=180, Recruiting, Sponsor: Hoffmann-La Roche
Trial primary completion date: Aug 2014 --> Sep 2015 Trial primary completion date: Jan 2016 --> Aug 2015
- ||| basmisanil (RG1662) / Roche
Trial initiation date: A Study of RG1662 in Adults and Adolescents With Down Syndrome (CLEMATIS) (clinicaltrials.gov) - May 13, 2014
P2, N=180, Recruiting, Sponsor: Hoffmann-La Roche
Trial primary completion date: Jan 2016 --> Aug 2015 Initiation date: Mar 2014 --> May 2014
- || basmisanil (RG1662) / Roche
Trial completion date: A Study of RG1662 in Adults and Adolescents With Down Syndrome (CLEMATIS) (clinicaltrials.gov) - May 13, 2014
P2, N=180, Recruiting, Sponsor: Hoffmann-La Roche
Initiation date: Mar 2014 --> May 2014 Trial completion date: Jan 2016 --> Aug 2015
- |||| basmisanil (RG1662) / Roche
Enrollment open: A Study of RG1662 in Adults and Adolescents With Down Syndrome (CLEMATIS) (clinicaltrials.gov) - May 13, 2014
P2, N=180, Recruiting, Sponsor: Hoffmann-La Roche
Trial completion date: Jan 2016 --> Aug 2015 Not yet recruiting --> Recruiting
- basmisanil (RG1662) / Roche
Trial initiation date: A Study of RG1662 in Individuals With Down Syndrome (clinicaltrials.gov) - May 11, 2014
P1, N=35, Completed, Sponsor: Hoffmann-La Roche
Not yet recruiting --> Recruiting Initiation date: Jan 2012 --> Nov 2011
- ||||| basmisanil (RG1662) / Roche
New P2 trial: A Study of RG1662 in Adults and Adolescents With Down Syndrome (CLEMATIS) (clinicaltrials.gov) - Dec 29, 2013
P2, N=180, Not yet recruiting, Sponsor: Hoffmann-La Roche
- | basmisanil (RG1662) / Roche
Trial completion: A Study of RG1662 in Individuals With Down Syndrome (clinicaltrials.gov) - Nov 12, 2013
P1, N=35, Completed, Sponsor: Hoffmann-La Roche
Initiation date: Jan 2012 --> Nov 2011 Recruiting --> Completed
- basmisanil (RG1662) / Roche
Enrollment change: A Molecular and Functional Brain Imaging Study in Individuals With Down Syndrome and Healthy Controls Following Single Dose RG1662 (clinicaltrials.gov) - Nov 4, 2013
P1, N=13, Completed, Sponsor: Hoffmann-La Roche
Recruiting --> Completed N=17 --> 13
- | basmisanil (RG1662) / Roche
Trial completion: A Molecular and Functional Brain Imaging Study in Individuals With Down Syndrome and Healthy Controls Following Single Dose RG1662 (clinicaltrials.gov) - Nov 4, 2013
P1, N=13, Completed, Sponsor: Hoffmann-La Roche
N=17 --> 13 Recruiting --> Completed
- ||| basmisanil (RG1662) / Roche
Enrollment open: A Screening Protocol to Assess Adults and Adolescents With Down Syndrome for Eligibility For Upcoming Study of RG1662 (Study BP27832) (clinicaltrials.gov) - Oct 6, 2013
P=N/A, N=170, Recruiting, Sponsor: Hoffmann-La Roche
Recruiting --> Completed Not yet recruiting --> Recruiting
- basmisanil (RG1662) / Roche
Trial completion: A 28-Day Pharmacokinetics Study of RG1662 in Healthy Male Volunteers (clinicaltrials.gov) - Oct 31, 2012
P1, N=6, Completed, Sponsor: Hoffmann-La Roche
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- basmisanil (RG1662) / Roche
New P1 trial: A 28-Day Pharmacokinetics Study of RG1662 in Healthy Male Volunteers (clinicaltrials.gov) - Sep 11, 2012
P1, N=6, Completed, Sponsor: Hoffmann-La Roche
- | basmisanil (RG1662) / Roche
New P1 trial: A Molecular and Functional Brain Imaging Study in Individuals With Down Syndrome and Healthy Controls Following Single Dose RG1662 (clinicaltrials.gov) - Aug 15, 2012
P1, N=13, Completed, Sponsor: Hoffmann-La Roche
- | basmisanil (RG1662) / Roche
New P1 trial: A Study of RG1662 in Individuals With Down Syndrome (clinicaltrials.gov) - Sep 18, 2011
P1, N=35, Completed, Sponsor: Hoffmann-La Roche